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Abstract 
Ranking the binding of small molecules to protein receptors through physics-based computation 
remains challenging. Though inroads have been made using free energy methods, these fail when 
the underlying classical mechanical force fields are insufficient. In principle, a more accurate 
approach is provided by quantum mechanical density functional theory (DFT) scoring, but even 
with approximations, this has yet to become practical on drug discovery-relevant timescales and 
resources. Here, we describe how to overcome this barrier using algorithms for DFT calculations 
that scale on widely available cloud architectures, enabling full density functional theory, without 
approximations, to be applied to protein-ligand complexes with approximately 2500 atoms in 
tens of minutes. Applying this to a realistic example of 22 ligands binding to MCL1 reveals that 
density functional scoring outperforms classical free energy perturbation theory for this system. 
This raises the possibility of broadly applying fully quantum mechanical scoring to real-world drug 
discovery pipelines. 
Introduction 
Quantum mechanics (QM) is the fundamental physical theory that governs the microscopic 
world, from atoms to molecules to proteins. However, to date, it has only played a minor role in 
screening ligands in drug discovery processes in the pharmaceutical industry, mainly because the 
computational demands required for solving the quantum mechanical equations are far greater 
than those for the classical counterparts. Because of this, it has been asserted that full QM 
simulations of protein-ligand complexes, i.e., those that do not introduce additional 
approximations, are “challenging, if not impossible” on discovery-relevant timescales1. This 
communication aims to demonstrate that through new algorithms, robust software engineering, 
and the use of commodity cloud resources, we can now perform quantum mechanical density 
functional theory (DFT/QM) calculations of entire protein-ligand complexes with a turnaround 
time relevant to lead optimization, without introducing approximations to the quantum 
   
 
   
 
mechanics beyond those inherent to DFT/QM itself. We call this approach highly efficient 
distributed-memory QM (hedQM). 
Computational methods in the drug discovery process can now be considered amongst the 
standard first-line approaches for moving from target identification to hits2. However, they have 
been less effective in later stages, i.e., going from hit-to-lead, where accurately ranking the 
binding affinities of multiple binders to a target protein is required. In the past decade, free 
energy calculation approaches, notably Free Energy Perturbation (FEP) and Thermodynamic 
Integration (TI)3,4 have been demonstrated, for some systems, to be capable of providing 
predictions of suitable accuracy and with suitable turnaround such that they can be used to focus 
the type of costly bench synthesis that characterizes end-stage lead optimization5,6. Despite this, 
methods like FEP remain limited with respect to the systems for which they are reliably 
predictive. There are several reasons for this, but many are related to limitations in the classical 
force field that lies at the heart of these approaches. While decades of work have led to 
reasonably predictive force fields, it is well understood that the force fields in wide use still 
struggle with many common interactions, e.g. polarization, metal coordination, common 
substituents such as halogens, covalency, and others7,8. It is also difficult to reliably apply 
common free energy methods to systems where the formal charge is changing on the ligand or 
in the protein environment, or to a non-congeneric series of ligands binding to the same protein 
receptor9. 
One solution to these limitations of free energy calculations is to instead use accurate first-
principles quantum mechanical methods, such as DFT/QM, for the characterization of ligand 
binding. DFT/QM obviates the need for either a force field form or atom-wise parameterization, 
can be used with arbitrary molecular moieties, and can deal natively with issues such as changes 
in valency, formal charge, and polarization. However, in the context of drug discovery time scales, 
full DFT/QM has not yet been practical to use in systems as large as protein-ligand complexes, 
and only more approximate, QM-derived approaches have been investigated in this context1. The 
two desirable but seemingly incompatible requirements are that (1) approximations should not 
suffer from similar limitations as force fields (or reintroduce errors on the scale of the few 
kcal/mol needed to discriminate between different ligands in realistic applications); (2) the 
computations should complete on the time scale of roughly an hour, to be relevant to real-world 
ligand optimization. While this has not been possible to date, the technical innovations we 
describe below now make it possible to carry out full DFT/QM calculations on protein-ligand 
complexes, without additional approximations, on time scales of a fraction of an hour. 
For a practical demonstration, we select the problem of rank-ordering ligand binding to induced 
myeloid leukemia cell differentiation protein (MCL1). It is critical to note, at the outset, that rank 
ordering is fundamentally the use case of greatest significance in real-world small molecule drug 
discovery because it addresses the question of which compounds to synthesize. The MCL1 system 
was chosen for a variety of reasons: (1) crystal structures have been published with a 
representative bound ligand; (2) binding data (in triplicate) for a series of binders has been 
   
 
   
 
measured by a single lab with a single approach and has been published; (3) the set is 
representative of the real-world application of lead optimization: unlike in some computational 
benchmarks, many of the binding affinities differ by less than 1 kcal/mol and thus the precise 
rank ordering is challenging to reproduce; (4) it is amenable to calculations not only within the 
DFT/QM approach we are attempting to demonstrate, but also by widely-used classical 
approaches, such as FEP and molecular mechanics with generalized Born and surface area 
continuum solvation (MM/GBSA)10. It is worth noting that results using the FEP method on this 
system have previously been published as part of a broader validation of the method (denoted 
as “FEP+” in Ref. 5). As we will demonstrate, using an agnostic protocol and no parameter fitting, 
full DFT/QM calculations can address the problem of rank ordering with an accuracy that is 
superior to protocols using FEP or MM/GBSA. 
Related approaches. As described above, full DFT/QM has typically been considered too 
expensive to directly apply to problems of lead optimization in protein-ligand binding. 
Consequently, a range of approximate DFT/QM-derived approaches have been explored such as 
QM/MM and other embedded QM methods11,12, fragmentation methods such as FMO and 
others13,14, semi-empirical QM including empirical tight-binding methods15–17, and direct linear-
scaling approximations18,19. Each technique has its strengths and there have been notable and 
impressive calculations with these approaches that suggest the potential of the full DFT/QM 
treatment12, but overall an unambiguous improvement in accuracy with respect to classical free 
energy methods has yet to be convincingly shown1. One issue is the faithfulness of these 
techniques to the underlying DFT/QM, as the approximations often manifest similar weaknesses 
to those found with classical force fields and can further introduce other errors which can be 
large on the scale of discriminating small ligand-binding enthalpies. For example, both QM/MM 
approaches and fragmentation methods treat only a region (or multiple small regions) with 
explicit DFT/QM and this leads to errors arising from the boundaries, as well as in the treatment 
of long-range charge polarization20. Semi-empirical QM (SEQM), e.g., the PM621 and DFTB 
models17, is extremely cheap and can be routinely applied to protein-ligand complexes, but 
reintroduces the problems of atom-specific parametrizations found in force-fields, and to date is 
far from being able to reliably match the accuracy of full DFT/QM, partly owing to an inability to 
properly describe polarization of electron density near charges. Finally, linear-scaling DFT 
algorithms have recently been applied to a few protein-ligand complexes18,19. However, while 
such linear-scaling approximations will eventually be required as we look towards larger and 
larger systems, the current numerical thresholds that control the cost introduce errors in the 
total energy on the scale of several kcal/mol18, which is a similar scale to the differences in the 
ligand-binding enthalpies found in realistic drug interactions. 
Beyond the issues annotated above, a second critical bottleneck in using these approximate 
DFT/QM methods in drug discovery applications is that the total wall time reported is still too 
long compared to the turnaround time needed for lead optimization. Since lead optimization 
often requires screening 100s of molecules, ideally each computation should typically not take 
more than an hour of wall time. However, for example, both fragment calculations (e.g. Ref. 20) 
   
 
   
 
and linear-scaling DFT calculations (e.g. Ref. 19) have reported wall times on the scale of a day to 
several days per protein-ligand complex, if a reasonable numerical accuracy is desired. 
For the above reasons, full DFT/QM remains the gold standard for QM calculations, and the 
ultimate goal is to be able to perform such calculations for the protein-ligand complex on the 
time scale of an hour or less. This is what we can now achieve using the algorithms that we 
describe in the following section. 
Methods 
HedQM on cloud architectures. To enable full QM calculations on protein-ligand complexes with 
high throughput, our strategy has been to design a core set of highly parallel DFT algorithms as 
part of the QSimulate-QM software platform. Rather than relying heavily on the tightly coupled 
nature of supercomputer hardware, we have designed our algorithms so that they can use 
generally available cloud computing resources, which employ commodity network interconnects. 
This requires optimizing the computational flow to minimize and hide communication wherever 
possible, as well as to ensure the calculation remains robust despite the dynamic nature of cloud 
computing hardware, where for example, spot instances may be taken away at any time. 
Using our implementation, we can now run parallel QM using vast computing resources available 
on the cloud. The cloud setting carries the advantage that almost arbitrarily large computational 
resources can be acquired on demand by any user. For example, we have carried out calculations 
with over 1000+ CPU cores and over 10+ TB of distributed memory on the Amazon Web Services 
platform. Furthermore, no hard disk space is necessary for computation in our implementation. 
This makes it possible to run a full QM calculation on a realistic protein-ligand system in a fraction 
of an hour, and due to the robustness of our platform, we can carry out simulations even on the 
cheapest “spot” instances, at a cost of approximately $0.02 per core hour. 
Algorithms. We base our full DFT/QM algorithm on the resolution-of-the-identity (RI-J) 
formulation22,23 using an auxiliary density expansion24 during orbital optimization (although we 
evaluate the final energy using the exact density). 
We precompute the two-electron, three-index electron repulsion integrals appearing in the RI-J 
algorithm and keep them in distributed memory in an atom-wise sparse format. To determine 
the sparsity, integral bounds25 are computed for the atomic orbital (AO) integrals with a very tight 
threshold (10-10). In the largest calculations, the three-index integrals amounted to about 6TB of 
distributed memory in total. We perform the metric inversion in RI-J using a Cholesky 
decomposition for performance and numerical stability. Exchange-correlation evaluation was 
carried out using the LibXC library26.  
All of the one-electron matrices, including the Cholesky-decomposed metric for RI, are 
distributed across the MPI processes in the block-cyclic format as detailed by the ScaLapack 
specification27, except for the density matrices that need to be replicated for Fock matrix 
evaluation. Likewise, all of the level-3 Basic Linear Algebra Subprogram (BLAS) operations 
   
 
   
 
(Cholesky decomposition, matrix-matrix multiplication, etc.) are performed using the ScaLapack 
library as implemented in Intel MKL, except for the diagonalization step that is performed by the 
ELPA library28. 
To avoid convergence issues that have plagued earlier DFT calculations on very large systems29, 
our algorithm uses a standard self-consistent procedure at the beginning of the calculation until 
the root-mean-square of the residual converges below 10-5. We then switch to an augmented 
Hessian algorithm with step restrictions to directly minimize the energy. In addition, we have 
observed that using implicit solvent in the earlier iterations stabilizes the SCF convergence in the 
first step; we include this using the standard conductor-like polarizable continuum (C-PCM) 
model using the ISWIG discretization30–32. The final augmented Hessian algorithm is then either 
run in the gas phase or with solvation as desired in the simulation. Note that the augmented 
Hessian algorithm is ideal for cloud hardware, especially close to convergence, because it is not 
communication-intensive, unlike traditional diagonalization. It also provides for reliable 
convergence even in the presence of the small HOMO-LUMO gaps often found in these systems, 
a problem previously considered highly challenging20,29. 
We have designed the inter-node communication in the DFT implementation to minimize the 
impact of interconnects with large latency (see below). Almost all the communication arises in 
the ScaLapack/ELPA libraries; some exceptions include the replication of density matrices 
(collective Allgather of a one-electron matrix) and Allreduce operations for small vectors. 
Runtime. All calculations were run using r5.24xlarge instances on Amazon Web Services (AWS) 
unless otherwise stated. The r5.24xlarge instances are one of the memory optimized instance 
types and consist of two Xeon Platinum CPUs, a total of 48 physical cores and 96 threads, and 
768 GB memory. The instances, instantiated in a so-called placement group, are connected by 25 
Gigabit Ethernet and used collectively by our message passing interface (MPI)-parallelized 
program. In addition to inter-node parallelization, the program is threaded for intra-node 
concurrency. We used 4 MPI processes per instance with up to 24 threads dedicated to each MPI 
process. The choice of instances is primarily based on the large memory requirements for the 
calculations and on the fact that there is no need for local hard disk storage (see above). We used 
12 r5.24xlarge spot instances for each of the MCL1 protein-ligand calculations, which took about 
40 minutes on average; the cost for each calculation for the full complex was around US$10. 
Preparation and scoring workflow. Starting from the PDB structure of MCL1 [PDB ID: 4HW3], the 
subsequent computational procedure required several steps: (1) protein preparation; (2) ligand 
docking; (3) refinement of the protein-ligand complex (i.e., geometry optimization); (4) scoring 
of the protein-ligand binding affinities. Additional details are provided in the supplementary 
information, and we highlight here only the essential points. To prepare the protein structure, 
(1) we neutralized residues that were far (> 7.5 Å) from the ligand, to better reflect their effective 
charges when placed in a solvated environment with counterions. For ligand docking (2) we used 
Smina33 to generate 10 poses per ligand (220 poses in total). To refine the protein-ligand complex 
(3) we used an Amgen in-house MM/GBSA protocol that was interfaced with Amber1834. Finally, 
   
 
   
 
for scoring binding in the protein-ligand complex (4), we used three different approaches for 
comparison: MM/GBSA10, the semi-empirical method GFN1-xTB using the implementation 
provided by Grimme’s group16, and DFT/QM. In each case, the binding energy was obtained by 
subtracting the energy of the ligand from the energy of the protein-ligand complex (note that 
since there was only a single protein, its energy did not need to be computed, and we did not do 
so in DFT/QM or SEQM). 
Initial scoring procedure. All 220 Smina poses were initially scored using MM/GBSA. Ligand strain 
was reduced by optimizing the bound ligand geometry. Out of these initial 220 poses, we retained 
only those within 7.5 kcal/mol of the lowest energy MM/GBSA pose by ligand, reducing the set 
to 67 poses. These 67 poses were then scored using either DFT/QM or SEQM to obtain the best 
pose for each of the 22 ligands and the final relative ligand binding energy. 
DFT/QM. DFT calculations on ligands bound to MCL1 were carried out using the revised PBE 
(revPBE) functional35 together with Grimme’s dispersion correction [D3(BJ)]36. We used revPBE-
D3(BJ) because it has been shown to perform well among pure DFT functionals in systems with 
non-covalent interactions37,38. The def2-SVP basis set39 was used for atoms belonging to residues 
within 10 Å of the ligand, and a minimum basis set derived from cc-pVTZ (MINAO) was used for 
the rest of the atoms40. Increasing the size of the region that included the larger def2-SVP basis 
did not change the results (see supplementary information). Using this basis, the numbers of 
primary and auxiliary Gaussian basis functions were approximately 15,200 and 49,000, 
respectively. The number of electrons and atoms were respectively approximately 9,400 and 
2,470. We also carried out the DFT calculations with and without solvation using C-PCM and the 
ISWIG discretization. 
Results 
Ranking ligand binding to MCL1. Ligand binding affinities to MCL1 (induced myeloid leukemia 
cell differentiation protein) have previously been used as one of the validation systems for 
Schrodinger’s FEP+ protocol. Ref. 41 provides a set of 42 ligands together with a measured set of 
dissociation constants (Ki) based on the skeleton shown at the bottom right of Fig. 1. To restrict 
the computational costs to our computational budget, out of the 42 ligands reported in their 
paper, we used the set of 22 homologous ligands where the aryl group (Ar) contains a single ring. 
These 22 ligands, along with associated Ki values, are shown in Fig. 1. The ligands vary in size from 
38 to 47 atoms. Note that the chosen ligands here span a 500-fold range in Ki, which is realistic 
for a later stage drug discovery effort. Distinguishing between these ligands and obtaining the 
correct rank ordering is thus a relevant test of the computational methodology. We characterize 
the performance of DFT/QM and its potential for ligand screening by computing the ligand 
binding affinities using a single structure, single energy application and use the results to rank 
order the ligands. A graphic of the entire system simulated using DFT/QM is shown in Fig. 2. 
   
 
   
 
 
Figure 1. Set of 22 ligands together with their Ki values. The numeric labels of the ligands are the ones 
taken from Ref. 41. The strongest and weakest binders are highlighted, as measured experimentally. The 
ligand skeleton used in Ref. 41 is shown at the bottom right. In this work, we considered the subset of 22 
ligands where the Ar group contained a single ring. 
 
Figure 2. The MCL1 binding domain (10 Å cutoff shown with blue ribbons) with a representative ligand 
(#37 from Fig. 2) in the binding pocket. The full ligand plus domain incorporates approximately 2500 
atoms. 
As a comparison, we will compare to the FEP results from Ref. 5 (using the OPLS2.1 force field) 
for rank ordering these ligands. However, on a theoretical level, the FEP results do not strictly 
provide an apples-to-apples comparison to our DFT/QM approach because they compute the 
free energy, rather than the electronic energy. Thus, for additional insight, we also present the 
binding energies within the single structure approach using the MM/GBSA method (the potential 
   
 
   
 
energy calculated using the force field augmented by a generalized Born treatment of the 
solvation energy), and a semi-empirical QM method, GFN1-xTB, that is designed specifically to 
improve the description of systems with non-covalent interactions16. One additional variable in 
the single structure approach is the choice of the unbound ligand geometry. We studied three 
choices with QM: (A) the ligand fixed at the geometry of the bound complex; (B) geometry of the 
free ligand optimized starting from the geometry of the bound complex to the nearest local 
minimum; and (C) geometry of the free ligand optimized to the global lowest energy conformer. 
Note that all optimizations were performed using MM/GBSA, the same method used to create 
the starting protein-ligand complex geometry, to maintain consistency. 
In Fig. 3 we show the rank orderings obtained for the 22 ligands using FEP, MM/GBSA, SEQM 
(GFN1-xTB), and QM (revPBE-D3(BJ)) together with three metrics that summarize the 
correlations: the coefficient of determination (R2), the Spearman rank correlation coefficient (), 
and the predictive index (PI). The FEP results are taken from Ref. 5. As a baseline, simple docking 
using the Smina docking package results in an R2 close to 0, when scored using the default 
Autodock Vina scoring function42, while docking and scoring using the Glide program43 using the 
SP scoring function results in an R2 around 0.42. 
The Spearman’s  coefficient summarizes the quality of the rank orderings of the methods. A 
correlation of 1 implies that the computed and experimental orderings of the binding affinities 
are identical. In fact, all methods perform reasonably well for the rank orderings, but the rank 
ordering obtained using the DFT/QM is appreciably better (10%) than that obtained using the 
other methods. FEP and MM/GBSA perform almost identically suggesting that entropic effects 
are either small or well correlated with enthalpic effects in this system, and SEQM is slightly 
better than both. 
Another metric with similar purpose, the Predictive Index (PI)44, also reflects rank ordering, and 
varies from 1 (perfect ranking) to 0 (entirely random), just like Spearman. But the Predictive Index 
weights contributions to the index by the experimental distance between the points being 
compared, thereby, e.g. reducing the importance of rank ordering for points that are effectively 
the same within experimental error. Surprisingly, evaluated using PI, FEP is inferior to all three 
other approaches, even MM-GBSA. 
The R2 value is a widely-reported measure of the correlation between the experimental and 
computational predictions. Although R2 is commonly presented, it is often a poor metric for 
characteristics of real importance, such as rank ordering. Again, by this metric, we find that 
DFT/QM performs significantly better than any other method; FEP+ and MM/GBSA perform 
almost identically to each other; and SEQM is slightly better than those methods, but still inferior 
to DFT. 
Note that while the predictions using methods other than FEP are quite capable of correctly 
predicting rank ordering, only FEP is expected (in cases where it works well) to fit a line with a 
slope of around 1 and an intercept around (0,0). The magnitudes of predictions using the other 
   
 
   
 
methods result in significantly different slopes and intercepts, as has been seen previously1,20. 
However, in practical use for later stage drug discovery, reliable rank ordering is appreciably more 
important than metrics like mean error. 
 
 
Figure 3. Predictions using various methods for a set of 22 ligands binding to MCL1. (A) DFT/QM, (B) FEP+ 
(from Ref. 5), (C) MM/GBSA, and (D) GFN1-xTB. The numbers in the circles correspond to the ligand 
numbers in Figure 1. DFT/QM provides the best correlations out of all the methods employed. For 
DFT/QM and GFN1-xTB, ligand strain is computed relative to the global minimum conformer, and ligand 
desolvation is taken into account. The predictive index (PI) reflects the ability to rank order the data, with 
each pairwise contribution weighted by the experimental distance between the corresponding pair of 
experimental observations44. 
   
 
   
 
We can obtain some insight into the physics involved in the DFT/QM ligand binding scoring by 
studying the component contributions to the energy. For example, we can examine the effect of 
solvation and ligand geometry relaxation (both to local and global minima) on the DFT rank 
orderings and R2 values. The correct computation of the ligand-binding enthalpy should include 
both desolvation and the (global) ligand strain effects. In Table 1, we show the R2 and Spearman 
rank coefficient obtained in the DFT/QM calculation as a function of the inclusion of these two 
contributions. For comparison, we also show the effect on the SEQM method GFN1-xTB. As we 
observe, removing either the ligand relaxation or solvation contribution worsens the R2 and 
Spearman coefficients. This suggests that the good performance of DFT/QM is correlated with 
the correct physics. The best R2 and  (0.75 and 0.88) are obtained when solvation is accounted 
for and the global minimum for each ligand is used to incorporate strain. In the case of GFN1-
xTB, although correlations comparable to the classical methods are reached, the results do not 
seem highly correlated with the contributions that are included. 
Table 1. R2 and Spearman rank correlation  for 6 different protocols to account for ligand strain and 
desolvation using DFT/QM and GFN1-xTB. Vacuum = no solvation; water = with solvation; b = ligand 
geometry is bound geometry; o = ligand geometry is local minimum near bound geometry; c = ligand 
geometry is lowest-energy conformer. DFT/QM yields the highest R2 and rank correlation when both 
solvation and full ligand relaxation is included, consistent with what would be expected from physical 
arguments. 
 
As a further test to support the hypothesis that the DFT/QM approach is obtaining good 
correlations for the right reasons, we assessed the correctness of the top pose (the one predicted 
to be energetically most favorable) for all 22 ligands across 12 different methodologies. The 
results are summarized in Fig. 4. While co-crystallized structures for all ligands are not available, 
the homology between the ligands suggests that we can assess the appropriateness of poses 
based on their similarity to the available co-crystallized ligand pose, and in particular by verifying 
that the fused 5/6 ring, linker, and aryl group are aligned with the crystal structure ligand. The 
red boxes indicate a protocol/ligand combination that results in an “incorrect” (i.e., dissimilar) 
pose being selected as the most energetically favorable one. The protocols differ with respect to 
method (QM vs. SEQM), the inclusion of solvation (vacuum vs. water), and ligand strain effects 
(b = ligand geometry is bound geometry; o = ligand geometry is local minimum near bound 
   
 
   
 
geometry; c = ligand geometry is lowest-energy conformer). Some examples of incorrect poses 
are shown in Fig. 5. From the 6 protocols considered in DFT/QM, only 3 manage to pick out the 
correct pose for all 22 ligands, and out of those, only two give reasonable R2 values. The ligand 
for which all GFN1-xTB protocols are unable to pick out the correct pose is the rightmost image 
in Fig. 5. It is reassuring that the best results are obtained when DFT is applied in the most 
physically sensible manner (accounting for solvation and ligand strain relative to the global 
minimum). SEQM (GFN1-xTB), on the other hand, fails to pick the correct pose for all ligands with 
any of the protocols. 
 
Figure 4. Pose identification for the 22 ligands (involving 67 total poses) using 6 different solvation 
protocols and ligand geometries (see main text and Figure 3 for description of protocols) for DFT/QM and 
GFN1-xTB. Green indicates that the “correct” pose is selected (as judged by similarity to co-crystallized 
ligand pose), while red indicates an “incorrect” pose. DFT/QM finds the correct pose for all 22 ligands 
when the relevant physical contributions of ligand solvation and strain relative to the lowest-energy 
conformer are included (protocol marked in yellow). 
   
 
   
 
Figure 5. Examples of ‘incorrect’ poses (in magenta) overlaid with ‘correct’ poses (in cyan) for 3 of the 22 
ligands considered in this study: 6, 25, 28 (from left to right). The crystal structure ligand from PDB ID: 
4HW3 is shown with white lines. 
Discussion 
It is undeniable that quantum mechanics—as embodied, for example, in modern DFT/QM 
calculations—is, in principle, the best approach to exploring many chemical phenomena. 
However, the enormous resource requirements of such calculations and the associated low 
throughput have traditionally limited the usefulness of QM for drug discovery. The approach we 
have described herein greatly ameliorates the throughput issue through the harnessing of large 
scale, distributed memory cloud resources. This means that we can examine a significant number 
of protein-ligand interactions using DFT/QM, on the timescale of a one-day project. While each 
protein-ligand calculation described in this work cost approximately $10 and took approximately 
40 minutes to complete, the turnaround time could be decreased further (at larger dollar cost) 
simply by increasing the number of cloud instances. Highly efficient distributed-memory QM 
(hedQM) on full protein-ligand systems is thus now practical. 
Because our approach does not require the use of additional approximations to the DFT/QM, we 
can also now understand the influence of quantum mechanics on protein-ligand binding free 
from other theoretical and numerical issues. Application of hedQM in an agnostic fashion to a 
series of inhibitors of the MCL1 protein and comparison to FEP results obtained in a previous 
publication for the same series of ligands demonstrates that DFT/QM performs better for this 
system by relevant metrics, such as R2, Spearman rank, or PI. 
Although our work suggests that hedQM calculations can now compete with FEP in terms of 
computational cost, and further carry the promise to substantially expand the domain of 
applicability versus FEP, it is important to note that with hedQM we are still practically limited to 
calculating potential energies for a relatively small number of poses or conformers. As a result, 
we cannot currently directly compute the configurational entropy for the system, and we need 
to rely on a combination of cancellation of contributions when comparing multiple ligands 
   
 
   
 
binding to a single receptor protein and corrections to the DFT/QM enthalpy. The good results 
we obtain using hedQM versus FEP in this communication demonstrate that the approach we 
describe is reasonable, however, because it is dependent on the geometry of a single (or a small 
number of) structures, in future work, we will further characterize this protocol across a broader 
set of proteins and ligands to evaluate its robustness in larger-scale protein-ligand screening. In 
addition, the combination of hedQM with approaches to obtain quantum mechanically corrected 
free energy contributions1, as well as machine learning approaches to reduce the number of fully 
quantum mechanical calculations45,46, are also natural avenues to explore, to extend this work to 
a more rigorous estimation of entropic contributions. Importantly, our work now places such 
investigations for drug discovery firmly within the domain of practical possibility, rather than 
simply fantasy. 
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